Cite
Gandouling ameliorates liver injury in Wilson's disease through the inhibition of ferroptosis by regulating the HSF1/HSPB1 pathway.
MLA
Zhao, Chenling, et al. “Gandouling Ameliorates Liver Injury in Wilson’s Disease through the Inhibition of Ferroptosis by Regulating the HSF1/HSPB1 Pathway.” Journal of Cellular & Molecular Medicine, vol. 28, no. 17, Sept. 2024, pp. 1–13. EBSCOhost, https://doi.org/10.1111/jcmm.70018.
APA
Zhao, C., Chen, J., Tian, L., Wen, Y., Wu, M., Tang, L., Zhou, A., Xie, W., & Dong, T. (2024). Gandouling ameliorates liver injury in Wilson’s disease through the inhibition of ferroptosis by regulating the HSF1/HSPB1 pathway. Journal of Cellular & Molecular Medicine, 28(17), 1–13. https://doi.org/10.1111/jcmm.70018
Chicago
Zhao, Chenling, Jie Chen, Liwei Tian, Yuya Wen, Mingcai Wu, Lulu Tang, An Zhou, Wenting Xie, and Ting Dong. 2024. “Gandouling Ameliorates Liver Injury in Wilson’s Disease through the Inhibition of Ferroptosis by Regulating the HSF1/HSPB1 Pathway.” Journal of Cellular & Molecular Medicine 28 (17): 1–13. doi:10.1111/jcmm.70018.